Edesa Biotech is a company headquartered in the United States.
Edesa Biotech is a clinical-stage biopharmaceutical company developing host-directed monoclonal antibody therapies to treat immune and inflammatory diseases, including acute respiratory distress syndrome (ARDS).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.